We are a leading European specialist pharmaceutical company with 110 years’ heritage. We have a presence in all major European markets and employ over 1,000 people. We operate a well-established European infrastructure to develop, manufacture and commercialise products.
What sets us apart from other companies is our flexible and agile approach to partnering and collaboration. We are able to integrate new products quickly for the benefit of healthcare systems and patients in Europe, Australia and New Zealand.
We are headquartered in the Netherlands. We own a R&D site in Hengoed, Wales and two manufacturing sites in Hengoed, Wales and Dreux, France.
In the UK, Norgine employs around 650 people. Norgine has two sites in the UK, one in Harefield and one in Hengoed.
Harefield site: The site houses several of Norgine’s global functions and Norgine’s UK Sales and Marketing operations. The site employs around 300 staff.
Hengoed site: In Wales, Norgine makes a considerable contribution to the growth of its life sciences sector. Norgine employs around 330 staff in Wales and is the largest pharmaceutical employer.The Hengoed manufacturing site was opened in 1969. The development center in Hengoed was opened in 2010, next to its manufacturing facilities.
Peter Stein, CEO
Our core values of One Norgine, Innovation and Trustworthiness underpin all of our activities. They are fundamental to achieving our vision.
We operate consistently throughout Norgine at all times, while remaining sensitive to local practices and cultural differences
We are flexible and agile and we look at new and better ways of working to make sure we continue to bring benefit for healthcare professionals, payers and patients in order to generate a financial return
We are patient centric and we act fairly, ethically and openly at all times